Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Pylclari
Pylclari
departments:
检验科
drug:
注射剂
Active:
Piflufolastat (18F)
indication:
Pylclari是一种诊断药物,用于患有前列腺癌症的成年人,通过称为正电子发射断层扫描(PET)的身体扫描,用一种称为前列腺特异性膜抗原(PSMA)的蛋白质检测前列腺癌症细胞。
Licensor:
Curium Pet France
Approved Country/Region:
欧盟
Approval time:
2023-07-24